abuse

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Source Node:
Time Stamp: September 20, 2023 8:36 AM - Modified On: September 20, 2023 - Published By:
Source Cluster:
Republished By Plato

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

Rock and Roll Hall of Famer Dave Mason to Join Sophia’s Mission as their National Spokesperson

Source Node:
Time Stamp: October 25, 2022 5:31 PM - Modified On: October 25, 2022 - Published By:
Source Cluster:
Republished By Plato

Dave Mason Spokesperson Announcements will be aired on Sophia’s Mission’s NEWHD Media Stations New York— 10/19/2022 — Father Zachary Martin, Founder of Sophia’s Mission and longtime friend of Dave Mason is proud to announce that beginning in November, Dave is joining his cause to serve as National Spokesperson. Sophia’s Mission is a registered 501©3 that advocates and creates meaningful employment for people living on the Autistic Spectrum and with Disabilities (ASD). Sophia’s Mission’s NEWHD Media, is making it possible for people with ASD and Disabilities to enter the exciting profession